Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research, development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anti-anemia, mental disorders, circulatory disorders, anti-psychotic, active pharmaceutical ingredients, and antidepressant medication. It also provides iron ...
Jilin Province Xidian Pharmaceutical Sci-Tech Development reported revenue of 234.84 million CNY for fiscal year 2025, down 8.4% from fiscal year 2024, and net income of 21.90 million CNY. In Q1 2026 (the quarter ended March 31, 2026) revenue was 55.93 million CNY, up 7.1% from a year before.
Figures from company filings; latest fiscal year ended December 31, 2025.
No profile data available.